MX355371B - Composiciones farmacéuticas combinadas y método de tratamiento del vértigo, la cinetosis y la distonía vegetativa-vascular. - Google Patents
Composiciones farmacéuticas combinadas y método de tratamiento del vértigo, la cinetosis y la distonía vegetativa-vascular.Info
- Publication number
- MX355371B MX355371B MX2013000805A MX2013000805A MX355371B MX 355371 B MX355371 B MX 355371B MX 2013000805 A MX2013000805 A MX 2013000805A MX 2013000805 A MX2013000805 A MX 2013000805A MX 355371 B MX355371 B MX 355371B
- Authority
- MX
- Mexico
- Prior art keywords
- vegetative
- treatment
- pharmaceutical compositions
- kinetosis
- vertigo
- Prior art date
Links
- 208000014094 Dystonic disease Diseases 0.000 title abstract 2
- 208000010118 dystonia Diseases 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 208000012886 Vertigo Diseases 0.000 title 1
- 231100000889 vertigo Toxicity 0.000 title 1
- 102000008299 Nitric Oxide Synthase Human genes 0.000 abstract 1
- 108010021487 Nitric Oxide Synthase Proteins 0.000 abstract 1
- 210000004556 brain Anatomy 0.000 abstract 1
- 230000003511 endothelial effect Effects 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- A61K2039/507—Comprising a combination of two or more separate antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Otolaryngology (AREA)
- Rheumatology (AREA)
Abstract
La presente invención se refiere a una composición homeopática que comprende a) una forma activada-potenciada de anticuerpo contra la proteína S-100 específica del cerebro y b) una forma activada-potenciada de anticuerpos contra la NOS endotelial.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2010130353/15A RU2542445C2 (ru) | 2010-07-21 | 2010-07-21 | Лекарственное средство для лечения болезни альцгеймера и способ лечения болезни альцгеймера |
RU2010130356/15A RU2542453C2 (ru) | 2010-07-21 | 2010-07-21 | Лекарственное средство и способ лечения вегето-сосудистой дистонии, синдрома головокружения различного генеза и кинетозов |
RU2011127058/15A RU2536232C2 (ru) | 2011-07-01 | 2011-07-01 | Лекарственное средство для лечения болезни альцгеймера и способ лечения болезни альцгеймера |
RU2011127052/15A RU2503462C2 (ru) | 2011-07-01 | 2011-07-01 | Способ лечения головокружения различного генеза, кинетозов и вегето-сосудистой дистонии (варианты) и лекарственное средство |
PCT/IB2011/002378 WO2012010974A2 (en) | 2010-07-21 | 2011-07-15 | Combination pharmaceutical compositions and method of treatment of vertigo, kinetosis and vegetative-vascular dystonia |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2013000805A MX2013000805A (es) | 2013-10-28 |
MX355371B true MX355371B (es) | 2018-04-17 |
Family
ID=44899157
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2013000805A MX355371B (es) | 2010-07-21 | 2011-07-15 | Composiciones farmacéuticas combinadas y método de tratamiento del vértigo, la cinetosis y la distonía vegetativa-vascular. |
Country Status (22)
Country | Link |
---|---|
US (1) | US20130058981A1 (es) |
EP (1) | EP2596018A2 (es) |
JP (2) | JP2013536174A (es) |
KR (1) | KR20130102542A (es) |
CN (1) | CN103124741A (es) |
AR (1) | AR082314A1 (es) |
AU (1) | AU2011281248B2 (es) |
BR (1) | BR112013001296A2 (es) |
CA (1) | CA2805985A1 (es) |
CL (1) | CL2013000201A1 (es) |
DE (1) | DE112011102397T5 (es) |
EA (1) | EA029998B1 (es) |
ES (1) | ES2446643R1 (es) |
FR (1) | FR2962910A1 (es) |
GB (1) | GB2496342B (es) |
IL (1) | IL224336A (es) |
IT (1) | ITTO20110630A1 (es) |
MX (1) | MX355371B (es) |
NZ (1) | NZ606988A (es) |
PE (1) | PE20131065A1 (es) |
SG (2) | SG187160A1 (es) |
WO (1) | WO2012010974A2 (es) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2181297C2 (ru) * | 2000-06-20 | 2002-04-20 | Эпштейн Олег Ильич | Способ лечения патологического синдрома и лекарственное средство |
UA76638C2 (en) | 2002-08-02 | 2006-08-15 | Oleh Illich Epshtein | Homeopathic medication based on anti-interferon antibodies and method for treating a pathological syndrome associated with interferon |
RU2309732C1 (ru) * | 2006-03-13 | 2007-11-10 | Олег Ильич Эпштейн | Спрессованная твердая оральная форма лекарственного препарата и способ получения твердой оральной формы лекарственного препарата |
SG187038A1 (en) * | 2010-07-15 | 2013-02-28 | Oleg Iliich Epshtein | A method of increasing the effect of an activated-potentiated form of an antibody |
CA2804967A1 (en) | 2010-07-15 | 2012-02-09 | Oleg Iliich Epshtein | Combination pharmaceutical composition and methods of treating diseases or conditions associated with neurodegenerative diseases |
ITTO20110641A1 (it) | 2010-07-15 | 2012-01-16 | Oleg Iliich Epshtein | Composizioni farmaceutiche e metodi di trattamento |
MX2013000807A (es) | 2010-07-21 | 2013-10-28 | Oleg Iliich Epshtein | Un metodo para el tratamiento del trastorno de hiperactividad con deficit de atencion. |
US20130058982A1 (en) * | 2010-07-21 | 2013-03-07 | Oleg Iliich Epshtein | Method of treating Alzheimer's disease |
FR2962909A1 (fr) | 2010-07-21 | 2012-01-27 | Oleg Iliich Epshtein | Composition pharmaceutique d'association et son utilisation dans des procedes pour traiter les maladies ou affections associees avec une maladie ou affection respiratoire |
EP2595658A2 (en) * | 2010-07-21 | 2013-05-29 | Oleg Iliich Epshtein | A combination pharmaceutical composition and methods of treating diabetes and metabolic disorders |
JP2013537532A (ja) * | 2010-08-06 | 2013-10-03 | イリイチ・エプシテイン オレグ | 感染性疾患を治療及び予防する組み合わせ医薬組成物及び方法 |
RU2013111962A (ru) | 2013-03-18 | 2014-09-27 | Олег Ильич Эпштейн | Способ определения выраженности модифицирующей активности, ассоциированной с носителем |
RU2013111961A (ru) | 2013-03-18 | 2014-09-27 | Олег Ильич Эпштейн | Способ определения выраженности модифицирующей активности, ассоциированной с носителем |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4311897A (en) | 1979-08-28 | 1982-01-19 | Union Carbide Corporation | Plasma arc torch and nozzle assembly |
RU2113230C1 (ru) | 1996-04-03 | 1998-06-20 | Ильчиков Михаил Захарович | Седативное лекарственное средство "авиаморе" |
US6150500A (en) * | 1996-07-12 | 2000-11-21 | Salerno; John C. | Activators of endothelial nitric oxide synthase |
US5849528A (en) * | 1997-08-21 | 1998-12-15 | Incyte Pharmaceuticals, Inc.. | Polynucleotides encoding a human S100 protein |
RU2156621C1 (ru) * | 1999-03-04 | 2000-09-27 | Эпштейн Олег Ильич | Нейротропное лекарственное средство |
RU2181297C2 (ru) * | 2000-06-20 | 2002-04-20 | Эпштейн Олег Ильич | Способ лечения патологического синдрома и лекарственное средство |
AU2002258518A1 (en) * | 2001-03-14 | 2002-09-24 | Millennium Pharmaceuticals, Inc. | Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer |
RU2201255C1 (ru) * | 2001-12-26 | 2003-03-27 | Эпштейн Олег Ильич | Лекарственное средство и способ регуляции сосудистого тонуса |
UA76638C2 (en) * | 2002-08-02 | 2006-08-15 | Oleh Illich Epshtein | Homeopathic medication based on anti-interferon antibodies and method for treating a pathological syndrome associated with interferon |
UA76641C2 (uk) * | 2002-08-02 | 2006-08-15 | Олєг Ільіч Епштєйн | Гомеопатичний лікарський засіб та спосіб лікування захворювань передміхурової залози |
UA76639C2 (uk) * | 2002-08-02 | 2006-08-15 | Олєг Ільіч Епштєйн | Гомеопатичний лікарський засіб та спосіб лікування еректильних дисфункцій |
JP2006516089A (ja) * | 2002-10-02 | 2006-06-22 | ジェネンテック・インコーポレーテッド | 腫瘍の診断と治療のための組成物と方法 |
CA2518965C (en) | 2003-03-14 | 2018-10-30 | Nutrition Research Inc. | Homeopathic formulations useful for treating pain and/or inflammmation |
CA2804967A1 (en) * | 2010-07-15 | 2012-02-09 | Oleg Iliich Epshtein | Combination pharmaceutical composition and methods of treating diseases or conditions associated with neurodegenerative diseases |
ITTO20110641A1 (it) * | 2010-07-15 | 2012-01-16 | Oleg Iliich Epshtein | Composizioni farmaceutiche e metodi di trattamento |
SG187038A1 (en) * | 2010-07-15 | 2013-02-28 | Oleg Iliich Epshtein | A method of increasing the effect of an activated-potentiated form of an antibody |
MX2013000807A (es) * | 2010-07-21 | 2013-10-28 | Oleg Iliich Epshtein | Un metodo para el tratamiento del trastorno de hiperactividad con deficit de atencion. |
FR2962909A1 (fr) * | 2010-07-21 | 2012-01-27 | Oleg Iliich Epshtein | Composition pharmaceutique d'association et son utilisation dans des procedes pour traiter les maladies ou affections associees avec une maladie ou affection respiratoire |
EP2595658A2 (en) * | 2010-07-21 | 2013-05-29 | Oleg Iliich Epshtein | A combination pharmaceutical composition and methods of treating diabetes and metabolic disorders |
US20130058982A1 (en) * | 2010-07-21 | 2013-03-07 | Oleg Iliich Epshtein | Method of treating Alzheimer's disease |
EP2596020A2 (en) * | 2010-07-21 | 2013-05-29 | Oleg Iliich Epshtein | Method of treatment of organic diseases of nervous system, psychoorganic syndrome and encephalopathy |
-
2011
- 2011-07-15 EA EA201300127A patent/EA029998B1/ru not_active IP Right Cessation
- 2011-07-15 SG SG2013004809A patent/SG187160A1/en unknown
- 2011-07-15 KR KR1020137004331A patent/KR20130102542A/ko not_active Application Discontinuation
- 2011-07-15 MX MX2013000805A patent/MX355371B/es active IP Right Grant
- 2011-07-15 EP EP11773316.2A patent/EP2596018A2/en not_active Ceased
- 2011-07-15 AU AU2011281248A patent/AU2011281248B2/en not_active Ceased
- 2011-07-15 GB GB1302925.1A patent/GB2496342B/en not_active Expired - Fee Related
- 2011-07-15 WO PCT/IB2011/002378 patent/WO2012010974A2/en active Application Filing
- 2011-07-15 SG SG10201505676RA patent/SG10201505676RA/en unknown
- 2011-07-15 US US13/135,887 patent/US20130058981A1/en not_active Abandoned
- 2011-07-15 FR FR1156477A patent/FR2962910A1/fr not_active Withdrawn
- 2011-07-15 IT IT000630A patent/ITTO20110630A1/it unknown
- 2011-07-15 BR BR112013001296A patent/BR112013001296A2/pt not_active IP Right Cessation
- 2011-07-15 CN CN2011800454598A patent/CN103124741A/zh active Pending
- 2011-07-15 ES ES201390010A patent/ES2446643R1/es active Pending
- 2011-07-15 NZ NZ606988A patent/NZ606988A/en not_active IP Right Cessation
- 2011-07-15 CA CA2805985A patent/CA2805985A1/en not_active Abandoned
- 2011-07-15 JP JP2013520240A patent/JP2013536174A/ja active Pending
- 2011-07-15 PE PE2013000111A patent/PE20131065A1/es not_active Application Discontinuation
- 2011-07-15 DE DE112011102397T patent/DE112011102397T5/de not_active Withdrawn
- 2011-07-21 AR ARP110102644A patent/AR082314A1/es unknown
-
2013
- 2013-01-20 IL IL224336A patent/IL224336A/en active IP Right Grant
- 2013-01-21 CL CL2013000201A patent/CL2013000201A1/es unknown
-
2016
- 2016-07-01 JP JP2016131718A patent/JP2016199571A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
CN103124741A (zh) | 2013-05-29 |
EA201300127A1 (ru) | 2013-12-30 |
WO2012010974A8 (en) | 2013-04-25 |
US20130058981A1 (en) | 2013-03-07 |
FR2962910A1 (fr) | 2012-01-27 |
ES2446643R1 (es) | 2015-03-06 |
CL2013000201A1 (es) | 2015-01-23 |
GB2496342A (en) | 2013-05-08 |
ITTO20110630A1 (it) | 2012-01-22 |
KR20130102542A (ko) | 2013-09-17 |
PE20131065A1 (es) | 2013-09-23 |
DE112011102397T5 (de) | 2013-05-08 |
IL224336A (en) | 2017-06-29 |
AR082314A1 (es) | 2012-11-28 |
AU2011281248A1 (en) | 2013-03-14 |
EA029998B1 (ru) | 2018-06-29 |
GB2496342B (en) | 2017-12-06 |
JP2013536174A (ja) | 2013-09-19 |
NZ606988A (en) | 2015-08-28 |
BR112013001296A2 (pt) | 2017-12-19 |
SG10201505676RA (en) | 2015-08-28 |
ES2446643A2 (es) | 2014-03-10 |
JP2016199571A (ja) | 2016-12-01 |
MX2013000805A (es) | 2013-10-28 |
CA2805985A1 (en) | 2012-01-26 |
WO2012010974A2 (en) | 2012-01-26 |
GB201302925D0 (en) | 2013-04-03 |
EP2596018A2 (en) | 2013-05-29 |
SG187160A1 (en) | 2013-02-28 |
AU2011281248B2 (en) | 2017-02-02 |
WO2012010974A3 (en) | 2012-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2496342A (en) | Combination pharmaceutical compositions and method of treatment of vertigo, kinetosis and vegetative-vascular dystonia | |
EA201590388A1 (ru) | Способы лечения таупатии | |
PH12015500390B1 (en) | Antibodies and vaccines for use in treating ror1 cancers and inhibiting metastasis | |
CY1121742T1 (el) | Αντισωματα s100a4 και θεραπευτικες χρησεις αυτων | |
PH12014502010A1 (en) | Bispecific antibodies against human tweak and human il17 and uses thereof | |
EA201390145A1 (ru) | Конъюгаты, частицы, композиции и связанные с ними способы | |
JO3118B1 (ar) | تراكيب وطرق لبروتين c5 المتمم يستهدف الأجسام المضادة | |
MX2012007684A (es) | Modificacion covalente ligando dirigida de proteina. | |
MX336682B (es) | Anticuerpos contra csf-1r humanos y usos de los mismos. | |
MX2012012928A (es) | Composiciones y metodos de uso para anticuerpos terapeuticos de proteina relacionada con lipoproteina de baja densidad 6 (lrp6). | |
MX346500B (es) | Metodos y composiciones para inmunoterapia para enfermedad neural. | |
PH12016500275A1 (en) | Antibodies | |
UA105073C2 (uk) | Антитіло проти фракталкіну, композиція і спосіб для лікування запальних порушень | |
AU2011217848A8 (en) | Integrin aVB8 neutralizing antibody | |
GB2496801A (en) | A method of treating alzheimer's disease | |
WO2012014078A3 (en) | Method of treatment of organic diseases of nervous system, psychoorganic syndrome and encephalopathy | |
MX2013002718A (es) | Composiciones de anticuerpo anti-vegfr-3. | |
AU2014286128B2 (en) | Human anti-IL-32 antibodies | |
TN2013000068A1 (en) | Anti-vegfr-3 antibody compositions | |
TN2011000041A1 (en) | Compositions and methods for antibodies targeting complement protein c5 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |